Clinical Trial Update: A Study of Nivolumab Safety and Pharmacokinetics in Patients With Severe Sepsis or Septic Shock. [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety and pharmacokinetics of nivolumab in patients with severe sepsis or septic shock; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Severe Sepsis | Phase 1 | Status: COMPLETED | Results posted: 2019-04-04